Quarterly report [Sections 13 or 15(d)]

Common Stock (Tables)

v3.25.1
Common Stock (Tables)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Summary of Stock Option Activity

A summary of stock option activity is presented below:

 

 

Number of
Shares

 

 

Weighted
Average
Exercise Price

 

 

Weighted
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding as of January 1, 2025

 

 

11,231,148

 

 

$

10.63

 

 

 

7.4

 

 

$

989

 

Granted

 

 

2,869,050

 

 

 

1.70

 

 

 

 

 

 

 

Forfeited/Cancelled

 

 

(33,993

)

 

 

15.18

 

 

 

 

 

 

 

Outstanding as of March 31, 2025

 

 

14,066,205

 

 

$

8.80

 

 

 

7.7

 

 

$

270

 

Options Exercisable at March 31, 2025

 

 

6,448,912

 

 

$

9.06

 

 

 

6.1

 

 

$

267

 

Schedule of Assumptions Used to Estimate Fair Value of Stock Options

The fair value of each award is estimated using Black-Scholes based on the following assumptions:

 

 

 

Three months ended March 31,

 

 

2025

 

2024

Risk-free interest rate

 

3.98%—4.46%

 

3.78%—4.28%

Expected term

 

6.1 years

 

6.1 years

Expected volatility

 

112%

 

106%

Expected dividend yield

 

0%

 

0%

Summary of Stock-Based Compensation

The Company has recorded stock-based compensation in the accompanying statements of operations as follows:

 

 

 

Three months ended
March 31,

 

 

 

2025

 

 

2024

 

Research and development

 

$

2,666

 

 

$

1,960

 

General and administrative

 

 

2,495

 

 

 

1,831

 

Total

 

$

5,161

 

 

$

3,791